ClinicalTrials.gg
Not yet recruitingNCT07935382PNF-CORE-GBSUpdated Nov 13, 2026

Effect of PNF + Core Strengthening Exercise in Sub-acute Guillain Barre Syndrome ( PNF-CORE-GBS )

An interventional study of Proprioceptive neuromuscular facilitation and core strengthening exercise in Guillain Barré Syndrome, sponsored by University of Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This randomized controlled trial will evaluate the effectiveness of proprioceptive neuromuscular facilitation combined with core strengthening exercises in Guillain barre syndrome patients .A total of 32 participants aged 18-45 years with clinically diagnosed sub-acute GBS will be allocated into two groups. The intervention group will receive PNF techniques combined with core strengthening exercises, while the control group will receive conventional physiotherapy. Both groups will participate in rehabilitation sessions four times per week for eight weeks.The primary outcomes include balance, muscle strength, and functional independence, assessed using the Berg Balance Scale (BBS), Manual Muscle Testing (MMT), and Barthel Index (BI), respectively. Assessments will be conducted at baseline, the fourth week, and the eighth week.The study purpose to determine whether combining PNF with core strengthening exercises provides additional benefits in improving rehabilitation outcomes in patients with sub-acute Guillain-Barré Syndrome.

Read the detailed description

Guillain-Barré Syndrome (GBS) is an acute immune-mediated inflammatory polyneuropathy characterized by rapidly progressive muscle weakness, diminished or absent deep tendon reflexes, sensory disturbances, impaired balance, and functional limitations in activities of daily living (ADLs). Although most patients recover gradually following the acute phase, many continue to experience persistent muscle weakness, impaired postural control, reduced trunk stability, and decreased functional independence during the subacute stage. Early rehabilitation plays a vital role in maximizing neurological recovery and improving functional outcomes. Conventional physiotherapy is considered a standard rehabilitation approach for patients with subacute GBS and typically includes range of motion exercises, muscle strengthening, balance training, gait training, and functional mobility exercises. However, there is limited evidence regarding the additional benefits of combining Proprioceptive Neuromuscular Facilitation (PNF) with core strengthening exercises in this population. Proprioceptive Neuromuscular Facilitation (PNF) is a therapeutic approach that uses proprioceptive stimulation, resistance, stretching, and coordinated movement patterns to facilitate neuromuscular activation and functional movement. Core strengthening exercises focus on improving trunk stability, pelvic control, postural alignment, and balance.

Although both interventions are used in neurological rehabilitation, evidence regarding the combined application of PNF and core strengthening exercises in patients with sub-acute GBS remains limited. Therefore, this study is designed to evaluate the effectiveness of combining these interventions compared with conventional physiotherapy.

This study is a randomized controlled trial involving 32 participants with clinically diagnosed sub-acute Guillain-Barré Syndrome. Participants will be recruited through non-probability purposive sampling from the Neuro-Medicine Ward and Physiotherapy Outpatient Department of Jinnah Postgraduate Medical Centre (JPMC), Karachi, Pakistan.

Eligible participants will be adults aged 18-45 years, of either gender, diagnosed with GBS and clinically stable for participation in physiotherapy rehabilitation. Participants will be randomly allocated into two groups using the sealed-envelope method. The outcome assessor will be blinded to group allocation.

Participants assigned to Group A will receive Proprioceptive Neuromuscular Facilitation (PNF) combined with core strengthening exercises.

The PNF intervention will include Contract-Relax (CR) and Contract-Relax-Antagonist-Contract (CRAC) techniques applied to the upper and lower extremities. The techniques will involve an initial stretch of approximately 10-20 seconds, followed by resisted muscle contraction lasting 3-6 seconds, with a relaxation period of approximately 2-3 seconds before further stretching.

Core strengthening exercises will include:

  • Pelvic control exercises.
  • Bridging exercises.
  • Curl-up exercises.
  • Curl-ups with diagonal reaching.
  • Bridging with crossed legs.
  • Single-leg bridging.
  • Side-bridging exercises. These exercises will target trunk and pelvic stability, neuromuscular control, and postural function.

*Control Group (Group B)*

Participants assigned to Group B will receive conventional physiotherapy, including:

  • Upper and lower extremity stretching and strengthening exercises.
  • Techniques for normalization of muscle tone.
  • Weight-bearing exercises.
  • Active functional training.
  • Postural control exercises.
  • Conventional balance training. Both groups will receive physiotherapy rehabilitation four times per week over eight weeks.

The study will evaluate the following outcome measures:

  1. Balance: Assessed using the Berg Balance Scale (BBS), which evaluates static and dynamic balance through 14 functional tasks. The total score ranges from 0 to 56.
  2. Muscle Strength: Assessed using Manual Muscle Testing (MMT), which evaluates muscle strength on a grading scale from 0 to 5.
  3. Functional Independence: Assessed using the Barthel Index (BI), which evaluates independence in activities of daily living, including feeding, bathing, dressing, transfers, mobility, and stair climbing. The total score ranges from 0 to 100.

Assessments will be performed at baseline, the fourth week, and the eighth week of the intervention.

The primary objective is to determine whether PNF combined with core strengthening exercises is more effective than conventional physiotherapy in improving balance, muscle strength, and functional independence among patients with sub-acute Guillain-Barré Syndrome.

02

Conditions studied

  • Guillain Barré Syndrome

Keywords

  • Guillain-Barre syndrome
  • proprioceptive neuromuscular facilitation
  • core strengthening
  • balance
  • strength
  • activity of daily living
  • neuro-rehabilitation
03

In context

Guillain-Barre Syndrome

98 studies on the registry are indexed under Guillain-Barre Syndrome; 30 are open to participants now.

This study's planned enrollment of 32 is below the median of 50 across 44 interventional studies indexed under Guillain-Barre Syndrome.

Browse Guillain-Barre Syndrome studies →

Lead sponsor

University of Lahore is the lead sponsor of 234 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • participants diagnosed with Guillain Barré Syndrome (GBS) based on neurological criteria
  • At the subacute or recovery stage of GBS, meaning within two to 12 weeks from disease onset
  • Age ranges from 18 to 45 years
  • Gender does not matter; both males and females can participate
  • Medical stability of the patient and being medically cleared to engage in intensive rehabilitation by a physical Ability to give

Exclusion Criteria:•Patients with cognitive disabilities and those who cannot follow commands

  • Patients with unstable heart and breathing rates and other systemic disease
  • Patients refusing to give their informed consent
  • Presence of musculoskeletal problems with balance problems (recent fractures, arthritis)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    PNF+Core strengthening Group

    Participants in the experimental group will receive Proprioceptive Neuromuscular Facilitation (PNF) combined with core strengthening exercises versus conventional physiotherapy. The intervention will be administered according to the study protocol over 4 times in week for 8-week period.

    Behavioral: Proprioceptive neuromuscular facilitation · Behavioral: core strengthening exercise

  • Active comparator
    conventional physiotheraphy Group

    conventional physical therapy Participants in the control group will receive conventional physiotherapy according to the standard rehabilitation protocol for patients with subacute Guillain-Barré Syndrome over 4 time per week for 8 week period

    Behavioral: conventional physiotherapy

Interventions

  • BehavioralProprioceptive neuromuscular facilitation

    Participants in the experimental group will receive PNF techniques, including Contract-Relax (CR) and Contract-Relax-Antagonist-Contract (CRAC), applied to the upper and lower extremities. The intervention will involve an initial stretch of 10-20 seconds, followed by resisted muscle contraction lasting 3-6 seconds, with approximately 2-3 seconds of rest between contractions and subsequent stretching. PNF will be combined with core strengthening exercises during the 8-week rehabilitation program.

  • Behavioralcore strengthening exercise

    Participants in the experimental group will perform core strengthening exercises targeting trunk and pelvic stability. Exercises will include pelvic control exercises, bridging, curl-ups, curl-ups with diagonal reaching, bridging with crossed legs, single-leg bridging, and side bridging. These exercises will be administered in combination with PNF techniques over an 8-week rehabilitation program.

  • Behavioralconventional physiotherapy

    Participants in the control group will receive conventional physiotherapy, including stretching and strengthening exercises for the upper and lower extremities, muscle tone normalization techniques, weight-bearing exercises, active functional training, postural control exercises, and conventional balance training. Treatment will be provided four times per week for eight weeks.

06

What researchers measure

Primary outcomes

  1. Balance

    Balance was assessed using the Berg Balance Scale (BBS) . The Berg Balance Scale is a 14-item clinical scale that measures static and dynamic balance. Scores range from 0 to 56, with higher scores indicating better balance and functional performance

    Time frame: Baseline , week 4 and week 8

  2. muscle strength

    Muscle strength was assessed using the Medical Research Council (MRC) Manual Muscle Testing scale. Muscle strength is graded from 0 to 5, where 0 indicates no muscle contraction and 5 indicates normal muscle strength. Higher scores indicate better muscle strength.

    Time frame: Baseline, week 4 and week 8

  3. Activities of Daily living (ADL)

    Activities of daily living were assessed using the Barthel Index (BI). The Barthel Index measures independence in activities of daily living. Scores range from 0 to 100, with higher scores indicating greater functional independence.

    Time frame: Baseline , week 4 and week 8

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2026
First posted
Nov 13, 2026
StartEst.
Nov 30, 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
May 30, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07935382
Responsible party
Sponsor
First posted
Nov 13, 2026
Start date
Nov 30, 2026 (estimated)
Primary completion
Apr 30, 2027 (estimated)
Completion
May 30, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Rida Rao, MSPTN
Contact
ridarao201@gmail.com
03153515825
kanwal Mirani, MSPTN
Contact
kanwalmiranikanwalmirani33@gmail.com
03123474874

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion